enGene Therapeutics Inc. (ENGN) has 5 open-market insider trades by 5 insiders since 2023. Over the last six months insiders net bought $10K. The most active filer is Forbion Growth Management B.V., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Forbion Growth Management B.V. | 10% Owner | — | 1 | $10.0M | 2024-10-30 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | — | 1 | $5.9M | 2024-10-08 |
| De Solidarite Des Travailleurs Du Quebec Fonds | 10% Owner | — | 1 | $857K | 2024-04-22 |
| Ronald Harold Wilfred Cooper | CEO | — | 1 | $57K | 2024-09-27 |
| William Grossman | — | — | 1 | $10K | 2026-09-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| William Grossman | — | Buy | $10K | 2026-09-22 |
| Forbion Growth Management B.V. | 10% Owner | Buy | $10.0M | 2024-10-30 |
| Ronald Harold Wilfred Cooper | CEO | Buy | $57K | 2024-09-27 |
| De Solidarite Des Travailleurs Du Quebec Fonds | 10% Owner | Sell | $857K | 2024-04-18 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | $5.9M | 2023-12-27 |
Companies that share insiders with ENGN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.